Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
1 other identifier
interventional
440
1 country
1
Brief Summary
The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2024
CompletedFirst Submitted
Initial submission to the registry
July 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedJuly 20, 2025
July 1, 2025
1 year
July 1, 2025
July 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Unscheduled return visits
The primary outcome will be unscheduled revisits to the emergency department or urgent care (binary endpoint, i.e., yes/no). This information will be obtained directly from the caregiver/parent of the child. One week (7 days) after the initial visit to the emergency department, research personnel will call the parent/caregiver to ask about length of symptoms and any unscheduled return visits to the emergency department or urgent care for the same symptoms. Any return visits to an emergency department or urgent care will be noted as yes. Well child visits will not be counted.
7 days
Secondary Outcomes (1)
Parental satisfaction
7 days
Study Arms (2)
Prescription for weight-based dosing of antipyretic
EXPERIMENTALThe intervention group (n=220) will receive prescription with weight-based dosing for acetaminophen (also known and prescribed as Tylenol) and ibuprofen (also known and prescribed as Motrin).
Standard discharge instructions
ACTIVE COMPARATORThe control group (n=220) will also receive standardized printed discharge instructions, which includes the appropriate dose of acetaminophen (also known as Tylenol) and ibuprofen (also known as Motrin) but no prescription.
Interventions
The intervention group (n=220) will receive prescription with weight-based dosing for acetaminophen (also prescribed and known as Tylenol) and ibuprofen (also prescribed and known as Motrin).
The control group (n=220) will also receive standardized printed discharge instructions but no prescription. The discharge instructions include the appropriate dose of acetaminophen (also known as Tylenol) and ibuprofen (also known as Motrin).
Eligibility Criteria
You may qualify if:
- Children 6 to \< 36 months of age being discharged home from Dell Children's Medical Center emergency department who are evaluated for fever
- Caregiver fluent in English or Spanish
You may not qualify if:
- Previous enrollment in this study
- Patient admitted to hospital
- Parental request for a prescription for acetaminophen and/or ibuprofen
- Trauma patient
- Orthopedic complaint
- Other painful indication for acetaminophen or ibuprofen
- Acetaminophen or ibuprofen prescribed for anything other than fever
- Allergy or another contraindication to acetaminophen or ibuprofen
- Parent and patient unlikely to follow up in the region (i.e., lives out of state)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dell Children's Medical Center
Austin, Texas, 78723, United States
Related Publications (2)
Section on Clinical Pharmacology and Therapeutics; Committee on Drugs; Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011 Mar;127(3):580-7. doi: 10.1542/peds.2010-3852. Epub 2011 Feb 28.
PMID: 21357332BACKGROUNDTrapani S, Fiordelisi A, Stinco M, Resti M. Update on Fever of Unknown Origin in Children: Focus on Etiologies and Clinical Approach. Children (Basel). 2023 Dec 24;11(1):20. doi: 10.3390/children11010020.
PMID: 38255334BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Matthew Wilkinson, MD, MPH
The University of Texas at Austin
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Manager
Study Record Dates
First Submitted
July 1, 2025
First Posted
July 20, 2025
Study Start
December 15, 2024
Primary Completion
December 31, 2025
Study Completion
March 15, 2026
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
IDP will not be shared to protect patient confidentiality.